Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds Vivaspaediatric-dermatology

Paeds Vivas · paediatric-dermatology

Congenital melanocytic naevi and pigmentary birthmarks — branching viva

Branching viva on the congenital pigmentary birthmarks: classifying the CMN by the projected adult size, stratifying the melanoma risk, recognising the neurocutaneous-melanocytosis risk pattern, and counselling the family on the surveillance and the management, branching to the pathophysiology, the surgery, the syndromic cafe-au-lait macule, and the dermal-melanocytosis child-protection distinction.

branching clinical structured oral3 min readVerification in progress

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
On this page
Study tools

Target exams

RACP DCEMRCPCH ClinicalRCPSC Pediatrics
Prompt
A six-week-old girl is brought with a large dark-brown, well-defined, slightly raised and hairy patch over the upper back present since birth, measuring fourteen by sixteen centimetres over the thoracic spine, with about a dozen smaller dark-brown satellite lesions over the back and the shoulders. The examiner asks: what is your diagnosis, how do you classify and risk-stratify the lesion, what is the management — then branches to the pathophysiology of the NRAS mosaicism, the neurocutaneous-melanocytosis risk and the imaging, the surgery and the prophylactic-excision principle, the six-or-more cafe-au-lait macules of the NF1, and the dermal-melanocytosis child-protection distinction.

Branching framework

Open with the one-sentence problem representation. This is a large congenital melanocytic naevus on the posterior axis (the thoracic spine) with multiple satellite nevi, in a well six-week-old girl. The decisive features are the size — the projected adult size falls in the large category — and the posterior-axis location with the satellites, which is the high-risk pattern for the neurocutaneous melanocytosis. State the recognition aloud — the brown, the raised and the hairy, the presence at the birth, the size, and the satellites — before you discuss the management. The examiner is listening for whether you stratify the risk before you reach for the plan. [2] [6]

Name the classification and the size-risk relationship. The CMN is classified by the projected adult size: the small under 1.5 cm, the medium 1.5 to 19.9 cm, the large 20 cm and over, the giant 50 cm and over. The melanoma risk tracks the size — near the population risk for the small and the medium, and elevated and concentrated in the childhood for the large and the giant. Be ready for the probe on the projected adult size: it is size lesion will reach in the adult, derived from the body-site-specific growth factor applied to the size at the presentation, and it is the correct denominator because the lesion grows with the child. [2] [1]

Branch to the pathophysiology. The CMN is caused by the postzygotic (mosaic) NRAS codon 61 mutation in the melanocyte lineage. The earlier and the more extensive the mutation, larger lesion, the more numerous the satellites, and greater chance of the leptomeningeal involvement, because the neural crest gives rise to both the skin and the central-nervous-system melanocytes. Be ready for the probe on the surgery: the prophylactic excision does not eliminate the melanoma risk, because the melanoma may arise in the residual cells, the satellites, or the central nervous system, so the observation and the surveillance, not the routine excision, are the mainstay. [6] [3]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Krengel S, Reyes-Múgica M. Melanoma risk in congenital melanocytic naevi. British Journal of Dermatology, 2017.PMID 28504374
  2. [2]Krengel S, Scope A, Dusza SW, et al. New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. Journal of the American Academy of Dermatology, 2013.PMID 22982004
  3. [3]Krengel S, Marghoob AA. Current management approaches for congenital melanocytic nevi. Dermatologic Clinics, 2012.PMID 22800546
  4. [6]Kinsler VA, Thomas AC, Ishida M, et al. Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. Journal of Investigative Dermatology, 2013.PMID 23392294
  5. [10]Dohil MA, Baugh WP, Eichenfield LF. Vascular and pigmented birthmarks. Pediatric Clinics of North America, 2000.PMID 10943257
  6. [11]Tey HL. A practical classification of childhood hypopigmentation disorders. Acta Dermato-Venereologica, 2010.PMID 20107718
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousApproach to rash in infants and children — vivapaediatric-dermatologyNextContact dermatitis — branching vivapaediatric-dermatology